---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-010035"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:25:50.051099+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Vistagen Therapeutics director Paul Edick resigns; board vacancy to be filled

## Summary
- Paul Edick resigned from the Board of Directors effective February 13, 2026.
- The Company is actively seeking new candidates to fill the resulting vacancy.
- No reason for resignation was disclosed in the filing.

## SEC filing metadata
- accession: 0001628280-26-010035
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000162828026010035/0001628280-26-010035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026010035/vtgn-20260213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-010035
- JSON: https://secwatch.observer/filing/0001628280-26-010035.json
- Plain text: https://secwatch.observer/filing/0001628280-26-010035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.